Pfizer Sues Novo Nordisk Over Metsera Drug Bid
Novo Nordisk’s Pfizer Challenge Signals a New Era of Pharma M&A and Obesity Drug Dominance The pharmaceutical landscape is bracing for a seismic shift. Pfizer’s legal challenge to Novo Nordisk’s proposed acquisition of Metsera isn’t simply a dispute over a single drugmaker; it’s a clear signal of escalating competition and a strategic land grab in … Read more